AHX Stock Overview
Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Apiam Animal Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.39 |
| 52 Week High | AU$0.56 |
| 52 Week Low | AU$0.23 |
| Beta | 0.29 |
| 1 Month Change | 22.22% |
| 3 Month Change | 20.31% |
| 1 Year Change | -23.00% |
| 3 Year Change | -56.50% |
| 5 Year Change | -19.79% |
| Change since IPO | -69.44% |
Recent News & Updates
Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%
Feb 24
These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively
Oct 12Recent updates
Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%
Feb 24These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively
Oct 12Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004
Sep 02Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Feb 28Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being
Nov 18Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012
Sep 15Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Sep 01A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)
Jun 10With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting
Apr 16Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend
Mar 14Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price
Mar 12Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)
Feb 25How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?
Feb 08
Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 18Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?
Dec 28Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price
Dec 11Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?
Nov 24Shareholder Returns
| AHX | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 4.1% | 2.2% | 0.9% |
| 1Y | -23.0% | -21.8% | 5.6% |
Return vs Industry: AHX underperformed the Australian Healthcare industry which returned -21.8% over the past year.
Return vs Market: AHX underperformed the Australian Market which returned 5.6% over the past year.
Price Volatility
| AHX volatility | |
|---|---|
| AHX Average Weekly Movement | 10.8% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: AHX has not had significant price volatility in the past 3 months.
Volatility Over Time: AHX's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 950 | Chris Richards | www.apiam.com.au |
Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals in Australia. The company operates through three segments: Dairy and Mixed, Feedlots, and Pigs. It engages in the provision of veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services.
Apiam Animal Health Limited Fundamentals Summary
| AHX fundamental statistics | |
|---|---|
| Market cap | AU$69.85m |
| Earnings (TTM) | AU$2.66m |
| Revenue (TTM) | AU$202.40m |
26.3x
P/E Ratio0.3x
P/S RatioIs AHX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AHX income statement (TTM) | |
|---|---|
| Revenue | AU$202.40m |
| Cost of Revenue | AU$160.50m |
| Gross Profit | AU$41.90m |
| Other Expenses | AU$39.24m |
| Earnings | AU$2.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.015 |
| Gross Margin | 20.70% |
| Net Profit Margin | 1.31% |
| Debt/Equity Ratio | 57.9% |
How did AHX perform over the long term?
See historical performance and comparison